GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,902 | +406.4% | 34,827 | +474.1% | 0.00% | – |
| Q2 2023 | $11,829 | +65616.7% | 6,066 | -9.3% | 0.00% | -100.0% |
| Q1 2023 | $18 | -14.3% | 6,689 | +11.7% | 0.00% | 0.0% |
| Q4 2022 | $21 | -99.9% | 5,990 | -51.4% | 0.00% | 0.0% |
| Q3 2022 | $31,000 | +138.5% | 12,325 | +134.0% | 0.00% | – |
| Q2 2022 | $13,000 | -86.7% | 5,266 | -77.9% | 0.00% | -100.0% |
| Q1 2022 | $98,000 | +71.9% | 23,855 | +438.7% | 0.00% | 0.0% |
| Q4 2021 | $57,000 | -66.1% | 4,428 | -71.5% | 0.00% | -75.0% |
| Q3 2021 | $168,000 | +158.5% | 15,524 | +116.9% | 0.00% | +100.0% |
| Q2 2021 | $65,000 | -30.1% | 7,157 | -26.9% | 0.00% | 0.0% |
| Q1 2021 | $93,000 | +244.4% | 9,787 | +43.9% | 0.00% | +100.0% |
| Q4 2020 | $27,000 | -69.0% | 6,800 | -79.3% | 0.00% | 0.0% |
| Q3 2020 | $87,000 | +93.3% | 32,841 | +385.6% | 0.00% | -50.0% |
| Q2 2020 | $45,000 | +542.9% | 6,763 | +739.1% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 806 | +56.5% | 0.00% | – |
| Q1 2019 | $7,000 | +600.0% | 515 | +560.3% | 0.00% | – |
| Q4 2018 | $1,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |